Simon Dew

Simon has over 20 years’ experience in pharmaceutical Business Development, Product Portfolio Strategy, Corporate Strategy and operational experience in international markets. Before joining Evox he was VP Corporate Strategy at Gyroscope Therapeutics and held leadership roles at Astellas in Corporate Strategy and Business Development. Over his career he has held Business Development and operational roles in Quintiles (IQVIA), Parexel, Phytopharm and international roles in GSK/SB. He is also currently an independent advisor to Sunstone Capital a Danish Venture Capital Company.